Iranian Journal of Radiology

Published by: Kowsar

Diffusion-Weighted Imaging and Proton Magnetic Resonance Spectroscopy Findings in Osteosarcoma Versus Normal Muscle

Mahrooz Malek 1 , Mohamad Ali Kazemi 1 , * , Sadegh Saberi 2 , Hassan Hashemi 1 and Behnaz Moradi 1
Authors Information
1 Advanced Diagnostic and Interventional Radiology Research Center (ADIR), Medical Imaging Center, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
2 Department of Orthopedic Surgery, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
Article information
  • Iranian Journal of Radiology: October 2017, 14 (4); e13937
  • Published Online: June 11, 2017
  • Article Type: Research Article
  • Received: April 19, 2016
  • Revised: February 10, 2017
  • Accepted: March 11, 2017
  • DOI: 10.5812/iranjradiol.13937

To Cite: Malek M, Kazemi M A, Saberi S, Hashemi H, Moradi B. Diffusion-Weighted Imaging and Proton Magnetic Resonance Spectroscopy Findings in Osteosarcoma Versus Normal Muscle, Iran J Radiol. 2017 ; 14(4):e13937. doi: 10.5812/iranjradiol.13937.

Abstract
Copyright © 2017, Iranian Journal of Radiology. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
References
  • 1. Xing D, Qasem SA, Owusu K, Zhang K, Siegal GP, Wei S. Changing prognostic factors in osteosarcoma: analysis of 381 cases from two institutions. Hum Pathol. 2014;45(8):1688-96. doi: 10.1016/j.humpath.2014.04.010. [PubMed: 24931466].
  • 2. Savage SA, Mirabello L. Using epidemiology and genomics to understand osteosarcoma etiology. Sarcoma. 2011;2011.
  • 3. Wittig JC, Bickels J, Priebat D, Jelinek J, Kellar-Graney K, Shmookler B, et al. Osteosarcoma: a multidisciplinary approach to diagnosis and treatment. Am Fam Physician. 2002;65(6):1123-32. [PubMed: 11925089].
  • 4. Chung WJ, Chung HW, Shin MJ, Lee SH, Lee MH, Lee JS, et al. MRI to differentiate benign from malignant soft-tissue tumours of the extremities: a simplified systematic imaging approach using depth, size and heterogeneity of signal intensity. Br J Radiol. 2014.
  • 5. Fayad LM, Wang X, Salibi N, Barker PB, Jacobs MA, Machado AJ, et al. A feasibility study of quantitative molecular characterization of musculoskeletal lesions by proton MR spectroscopy at 3 T. AJR Am J Roentgenol. 2010;195(1):W69-75. doi: 10.2214/AJR.09.3718. [PubMed: 20566784].
  • 6. Costa FM, Canella C, Gasparetto E. Advanced magnetic resonance imaging techniques in the evaluation of musculoskeletal tumors. Radiol Clin North Am. 2011;49(6):1325-58. vii-viii. doi: 10.1016/j.rcl.2011.07.014. [PubMed: 22024301].
  • 7. Deshmukh S, Subhawong T, Carrino JA, Fayad L. Role of MR spectroscopy in musculoskeletal imaging. Indian J Radiol Imaging. 2014;24(3):210-6. doi: 10.4103/0971-3026.137024. [PubMed: 25114383].
  • 8. Wang CK, Li CW, Hsieh TJ, Chien SH, Liu GC, Tsai KB. Characterization of bone and soft-tissue tumors with in vivo 1H MR spectroscopy: initial results. Radiology. 2004;232(2):599-605. doi: 10.1148/radiol.2322031441. [PubMed: 15286325].
  • 9. Abrantes AM, Rio J, Tavares LC, Carvalho RA, Botelho MF. Magnetic resonance spectroscopy in cancer diagnostics. Oncol Rev. 2011;4(3):177. doi: 10.4081/oncol.2010.177.
  • 10. Maheshwari SR, Mukherji SK, Neelon B, Schiro S, Fatterpekar GM, Stone JA, et al. The choline/creatine ratio in five benign neoplasms: comparison with squamous cell carcinoma by use of in vitro MR spectroscopy. AJNR Am J Neuroradiol. 2000;21(10):1930-5. [PubMed: 11110549].
  • 11. Fayad LM, Barker PB, Bluemke DA. Molecular characterization of musculoskeletal tumors by proton MR spectroscopy. Semin Musculoskelet Radiol. 2007;11(3):240-5. doi: 10.1055/s-2008-1038313. [PubMed: 18260034].
  • 12. Lee CW, Lee JH, Kim DH, Min HS, Park BK, Cho HS, et al. Proton magnetic resonance spectroscopy of musculoskeletal lesions at 3 T with metabolite quantification. Clin Imaging. 2010;34(1):47-52. doi: 10.1016/j.clinimag.2009.03.013. [PubMed: 20122519].
  • 13. Fayad LM, Jacobs MA, Wang X, Carrino JA, Bluemke DA. Musculoskeletal tumors: how to use anatomic, functional, and metabolic MR techniques. Radiology. 2012;265(2):340-56. doi: 10.1148/radiol.12111740. [PubMed: 23093707].
  • 14. Malek M, Pourashraf M, Mousavi AS, Rahmani M, Ahmadinejad N, Alipour A, et al. Differentiation of benign from malignant adnexal masses by functional 3 tesla MRI techniques: diffusion-weighted imaging and time-intensity curves of dynamic contrast-enhanced MRI. Asian Pac J Cancer Prev. 2015;16(8):3407-12. [PubMed: 25921153].
  • 15. Khoo MM, Tyler PA, Saifuddin A, Padhani AR. Diffusion-weighted imaging (DWI) in musculoskeletal MRI: a critical review. Skeletal Radiol. 2011;40(6):665-81. doi: 10.1007/s00256-011-1106-6. [PubMed: 21311884].
  • 16. Oka K, Yakushiji T, Sato H, Hirai T, Yamashita Y, Mizuta H. The value of diffusion-weighted imaging for monitoring the chemotherapeutic response of osteosarcoma: a comparison between average apparent diffusion coefficient and minimum apparent diffusion coefficient. Skeletal Radiol. 2010;39(2):141-6. doi: 10.1007/s00256-009-0830-7. [PubMed: 19924412].
  • 17. Dudeck O, Zeile M, Pink D, Pech M, Tunn PU, Reichardt P, et al. Diffusion-weighted magnetic resonance imaging allows monitoring of anticancer treatment effects in patients with soft-tissue sarcomas. J Magn Reson Imaging. 2008;27(5):1109-13. doi: 10.1002/jmri.21358. [PubMed: 18425832].
  • 18. Schieda N, Al-Dandan O, El-Khodary M, Shabana W. Low b-value (black blood) respiratory-triggered fat-suppressed single-shot spin-echo echo-planar imaging (EPI) of the liver: comparison of image quality at 1.5 and 3 T. Clin Radiol. 2014;69(11):1136-41. doi: 10.1016/j.crad.2014.06.017. [PubMed: 25060933].
  • 19. Doganay S, Altinok T, Alkan A, Kahraman B, Karakas HM. The role of MRS in the differentiation of benign and malignant soft tissue and bone tumors. Eur J Radiol. 2011;79(2):e33-7. doi: 10.1016/j.ejrad.2010.12.089. [PubMed: 21376496].
  • 20. Hayashida Y, Yakushiji T, Awai K, Katahira K, Nakayama Y, Shimomura O, et al. Monitoring therapeutic responses of primary bone tumors by diffusion-weighted image: Initial results. Eur Radiol. 2006;16(12):2637-43. doi: 10.1007/s00330-006-0342-y. [PubMed: 16909220].
  • 21. Yakushiji T, Oka K, Sato H, Yorimitsu S, Fujimoto T, Yamashita Y, et al. Characterization of chondroblastic osteosarcoma: gadolinium-enhanced versus diffusion-weighted MR imaging. J Magn Reson Imaging. 2009;29(4):895-900. doi: 10.1002/jmri.21703. [PubMed: 19306430].
  • 22. Oya N, Aoki J, Shinozaki T, Watanabe H, Takagishi K, Endo K. Preliminary study of proton magnetic resonance spectroscopy in bone and soft tissue tumors: an unassigned signal at 2.0-2.1 ppm may be a possible indicator of malignant neuroectodermal tumor. Radiat Med. 2000;18(3):193-8. [PubMed: 10972550].
  • 23. Fayad LM, Bluemke DA, McCarthy EF, Weber KL, Barker PB, Jacobs MA. Musculoskeletal tumors: use of proton MR spectroscopic imaging for characterization. J Magn Reson Imaging. 2006;23(1):23-8. doi: 10.1002/jmri.20448. [PubMed: 16315208].
  • 24. Fayad LM, Barker PB, Jacobs MA, Eng J, Weber KL, Kulesza P, et al. Characterization of musculoskeletal lesions on 3-T proton MR spectroscopy. AJR Am J Roentgenol. 2007;188(6):1513-20. doi: 10.2214/AJR.06.0935. [PubMed: 17515370].
  • 25. Nelson SJ. Multivoxel magnetic resonance spectroscopy of brain tumors. Mol Cancer Ther. 2003;2(5):497-507. [PubMed: 12748312].
  • 26. Michaelis T, Merboldt KD, Bruhn H, Hanicke W, Frahm J. Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra. Radiology. 1993;187(1):219-27. doi: 10.1148/radiology.187.1.8451417. [PubMed: 8451417].
  • 27. Qi ZH, Li CF, Li ZF, Zhang K, Wang Q, Yu DX. Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors. Chin Med J (Engl). 2009;122(1):39-43. [PubMed: 19187615].
  • 28. Fayad LM, Salibi N, Wang X, Machado AJ, Jacobs MA, Bluemke DA, et al. Quantification of muscle choline concentrations by proton MR spectroscopy at 3 T: technical feasibility. AJR Am J Roentgenol. 2010;194(1):W73-9. doi: 10.2214/AJR.09.3125. [PubMed: 20028894].
  • 29. Ottaviani G, Jaffe N. The epidemiology of osteosarcoma. Pediatric and adolescent osteosarcoma. Springer; 2009.
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments